Jobs Affected as ImmunoGen Winds Down Ops at Massachusetts Facility Post author:Sam Post published:February 13, 2018 Post category:BioPharma ImmunoGen gave a pipeline progress report and 2017 operating results last week. Source: BioSpace You Might Also Like Why This Biotech CEO Injected Himself With a DIY Herpes Vaccine on Facebook Live February 5, 2018 Why This Overlooked Seattle Drugmaker Could be the Best Biotech Buy Right Now November 28, 2017 Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy February 23, 2017
Buyers Remorse: Merck & Co. Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix Buy February 23, 2017
